Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | HTR1B | P28222 | 11/20 | 0.59 |
| ▸ | HTR1D | P28221 | 2/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.57 |
| ▸ | HRH1 | P35367 | 1/20 | 0.57 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.56 |
| ▸ | KDM1A | O60341 | 1/20 | 0.56 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL667325 | 1.00 | KDM4E (0.61) | KDM4EALDH1A1MEN1KMT2AHTR1B | |
| SCHEMBL30007810 | 0.95 | HTR1B (0.65) | KDM4EALDH1A1HTR1BHTR1DSLC6A4 | |
| SCHEMBL667918 | 0.95 | HTR1B (0.65) | KDM4EALDH1A1HTR1BHTR1DSLC6A4 | |
| SCHEMBL8674828 | 0.91 | HTR1B (0.69) | KDM4EALDH1A1MEN1KMT2AHTR1B | |
| SCHEMBL8642238 | 0.91 | HTR1B (0.69) | KDM4EALDH1A1MEN1KMT2AHTR1B | |
| SCHEMBL11057929 | 0.88 | KCNA3 (0.54) | KDM4EALDH1A1MEN1KMT2AHTR1B | |
| SCHEMBL28082844 | 0.86 | KDM4E (0.61) | KDM4EALDH1A1MEN1KMT2AHTR1B | |
| SCHEMBL30359494 | 0.86 | NCF1 (0.49) | KDM4EALDH1A1MEN1KMT2AHTR1B | |
| SCHEMBL10984843 | 0.86 | KCNA3 (0.69) | MEN1KMT2AHTR1BHTR1DSLC6A4 | |
| SCHEMBL28855276 | 0.85 | KDM4E (0.47) | KDM4EALDH1A1MEN1KMT2AHTR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8535869-B2 | Sulfonium salt, resist composition, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-09-17 | — | — | US | disclosed |
| US-20120045724-A1 | SULFONIUM SALT, RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120045724-A1 | SULFONIUM SALT, RESIST COMPOSITION, AND PATTERNING PROCESS | SLC6A5, NES, STS | KDM4E 2229/4885ALDH1A1 3412/4885MEN1 4434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.